Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vernon M Chinchilli

Showing results (251-260 of 320) with videos related to

Pageof 32
Sort By:
Contemporary Clinical Trials|December 30, 2018
Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine eraChristine A Sorkness, Tonya S King, Anne-Marie Dyer, et al.
JAMA Network Open|April 14, 2020
Association Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical OutcomesPavan K Bhatraju, Leila R Zelnick, Vernon M Chinchilli, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 18, 2014
Effects of inhaled fluticasone on upper airway during sleep and wakefulness in asthma: a pilot studyMihaela Teodorescu, Ailiang Xie, Christine A Sorkness, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroidsAaron Deykin, Stephen C Lazarus, John V Fahy, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2008
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma studyRobert C Strunk, Leonard B Bacharier, Brenda R Phillips, et al.
Kidney International|July 25, 2020
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and deathT Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb, et al.
JCI Insight|March 23, 2023
Longitudinal biomarkers and kidney disease progression after acute kidney injuryYumeng Wen, Leyuan Xu, Isabel Melchinger, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2005
beta-Adrenergic receptor polymorphisms and response to salmeterolMichael E Wechsler, Erik Lehman, Stephen C Lazarus, et al.
The Journal of Clinical Investigation|December 8, 2020
Biomarkers of inflammation and repair in kidney disease progressionJeremy Puthumana, Heather Thiessen-Philbrook, Leyuan Xu, et al.
BMC Nephrology|July 30, 2021
Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort studyIan McCoy, Sandeep Brar, Kathleen D Liu, et al.
Pageof 32

Showing results (251-260 of 320) with videos related to

Sort By:
Pageof 32
Contemporary Clinical Trials|December 30, 2018
Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine eraChristine A Sorkness, Tonya S King, Anne-Marie Dyer, et al.
JAMA Network Open|April 14, 2020
Association Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical OutcomesPavan K Bhatraju, Leila R Zelnick, Vernon M Chinchilli, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 18, 2014
Effects of inhaled fluticasone on upper airway during sleep and wakefulness in asthma: a pilot studyMihaela Teodorescu, Ailiang Xie, Christine A Sorkness, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroidsAaron Deykin, Stephen C Lazarus, John V Fahy, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2008
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma studyRobert C Strunk, Leonard B Bacharier, Brenda R Phillips, et al.
Kidney International|July 25, 2020
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and deathT Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb, et al.
JCI Insight|March 23, 2023
Longitudinal biomarkers and kidney disease progression after acute kidney injuryYumeng Wen, Leyuan Xu, Isabel Melchinger, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2005
beta-Adrenergic receptor polymorphisms and response to salmeterolMichael E Wechsler, Erik Lehman, Stephen C Lazarus, et al.
The Journal of Clinical Investigation|December 8, 2020
Biomarkers of inflammation and repair in kidney disease progressionJeremy Puthumana, Heather Thiessen-Philbrook, Leyuan Xu, et al.
BMC Nephrology|July 30, 2021
Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort studyIan McCoy, Sandeep Brar, Kathleen D Liu, et al.
Pageof 32